BACTERICIDAL ACTIVITY INVITRO OF VARIOUS RIFAMYCINS AGAINST MYCOBACTERIUM-AVIUM AND MYCOBACTERIUM-TUBERCULOSIS

被引:106
作者
HEIFETS, LB
LINDHOLMLEVY, PJ
FLORY, MA
机构
[1] UNIV COLORADO,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262
来源
AMERICAN REVIEW OF RESPIRATORY DISEASE | 1990年 / 141卷 / 03期
关键词
D O I
10.1164/ajrccm/141.3.626
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Minimal inhibitory and bactericidal concentrations (MICs and MBCs) of rifampin (RMP), rifabutin (RBT), rifapentine (RPT), CGP-7040, and P-DEA, were determined for 50 M. avium strains in 7H12 liquid medium radiometrically under various pH conditions. Half were isolated from patients with AIDS and the other half from patients without AIDS but with pulmonary disease. The MICs and MBCs were also determined in 7H12 broth for M. tuberculosis strains. The MIC results obtained with M. tuberculosis strains, and the serum peak levels in humans, were used as standards for interpretation of the MICs and MBCs of the rifamycins for M. avium. The bactericidal activity of all rifamycins for M. avium was substantially lower than for M. tuberculosis. The majority of M. avium strains was within the 'susceptible' category, e.g., comparable to susceptible M. tuberculosis strains, when tested with CGP-7040 and RPT, and all of them were 'moderately susceptible' when tested with P-DEA. On the basis of in vitro bacteriostatic and bactericidal activity, it seems that three agents, RPT, P-DEA, and CGP-7040 have more potential than do RMP and RBT against M. avium disease.
引用
收藏
页码:626 / 630
页数:5
相关论文
共 37 条
[1]   ANTI-BACTERIAL ACTIVITY OF DL-473, A NEW SEMI-SYNTHETIC RIFAMYCIN DERIVATIVE [J].
ARIOLI, V ;
BERTI, M ;
CARNITI, G ;
RANDISI, E ;
ROSSI, E ;
SCOTTI, R .
JOURNAL OF ANTIBIOTICS, 1981, 34 (08) :1026-1032
[2]   PHARMACOKINETICS OF RIFAPENTINE, A NEW LONG LASTING RIFAMYCIN, IN THE RAT, THE MOUSE AND THE RABBIT [J].
ASSANDRI, A ;
RATTI, B ;
CRISTINA, T .
JOURNAL OF ANTIBIOTICS, 1984, 37 (09) :1066-1075
[3]   INTRACELLULAR KILLING OF MYCOBACTERIUM-AVIUM COMPLEX BY RIFAPENTINE AND LIPOSOME-ENCAPSULATED AMIKACIN [J].
BERMUDEZ, LEM ;
WU, M ;
YOUNG, LS .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (03) :510-513
[4]   ANTIBACTERIAL ACTIVITY IN SERUM AND URINE FOLLOWING ORAL-ADMINISTRATION IN MAN OF DL473 (A CYCLOPENTYL DERIVATIVE OF RIFAMPICIN) [J].
BIRMINGHAM, AT ;
COLEMAN, AJ ;
ORME, MLE ;
PARK, BK ;
PEARSON, NJ ;
SHORT, AH ;
SOUTHGATE, PJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) :P455-P456
[5]   COMPARATIVE INVITRO ACTIVITIES OF MDL 473, RIFAMPIN, AND ANSAMYCIN AGAINST MYCOBACTERIUM-INTRACELLULARE [J].
CYNAMON, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (03) :440-441
[6]  
DELLABRUNA C, 1983, J ANTIBIOT, V36, P1502
[7]  
DICKINSON JM, 1981, AM REV RESPIR DIS, V123, P367
[8]   INVITRO ACTIVITY OF NEW RIFAMYCINS AGAINST RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS AND MAIS-COMPLEX MYCOBACTERIA [J].
DICKINSON, JM ;
MITCHISON, DA .
TUBERCLE, 1987, 68 (03) :177-182
[9]   INVITRO OBSERVATIONS ON THE SUITABILITY OF NEW RIFAMYCINS FOR THE INTERMITTENT CHEMOTHERAPY OF TUBERCULOSIS [J].
DICKINSON, JM ;
MITCHISON, DA .
TUBERCLE, 1987, 68 (03) :183-193
[10]   INVITRO PROPERTIES OF RIFAPENTINE (MDL473) RELEVANT TO ITS USE IN INTERMITTENT CHEMOTHERAPY OF TUBERCULOSIS [J].
DICKINSON, JM ;
MITCHISON, DA .
TUBERCLE, 1987, 68 (02) :113-118